V. Grinevich

发表

Understanding the Role α7 Nicotinic Receptors Play in Dopamine Efflux in Nucleus Accumbens

R. Maex, B. Gutkin, E. Budygin, 2014, ACS chemical neuroscience.

Applying a Fast-Scan Cyclic Voltammetry to Explore Dopamine Dynamics in Animal Models of Neuropsychiatric Disorders

R. Gainetdinov, E. Budygin, V. Grinevich, 2022, Cells.

QM-polarized ligand docking accurately predicts the trend in binding affinity of a series of arylmethylene quinuclidine-like derivatives at the α4β2 and α3β4 nicotinic acetylcholine receptors (nAChRs).

D. Kombo, T. Hauser, M. Bencherif, 2013, Bioorganic & medicinal chemistry letters.

Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.

L. Dwoskin, P. Crooks, S. Norrholm, 2010, Bioorganic & medicinal chemistry.

N-n-Alkylnicotinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Interaction with α4β2* and α7* Neuronal Nicotinic Receptors

L. Dwoskin, P. Crooks, J. T. Ayers, 2003, Journal of Pharmacology and Experimental Therapeutics.

N-n -Alkylnicotinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Interaction with (cid:1) 4 (cid:2) 2* and (cid:1) 7* Neuronal Nicotinic Receptors

L. Dwoskin, P. Crooks, J. T. Ayers, 2002 .

Heterologous expression of human {alpha}6{beta}4{beta}3{alpha}5 nicotinic acetylcholine receptors: binding properties consistent with their natural expression require quaternary subunit assembly including the {alpha}5 subunit.

R. Lukas, M. Bencherif, J. Bénavidès, 2005, Journal of Pharmacology and Experimental Therapeutics.

Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues.

L. Dwoskin, P. Crooks, L. Dwoskin, 2001, Bioorganic & medicinal chemistry letters.

Selective targeting of melanoma using N-(2-diethylaminoethyl) 4-[18F]fluoroethoxy benzamide (4-[18F]FEBZA): a novel PET imaging probe

P. Garg, S. Garg, V. Grinevich, 2017, EJNMMI Research.

Short-Term Consequences of Single Social Defeat on Accumbal Dopamine and Behaviors in Rats

R. Gainetdinov, E. Budygin, A. Deal, 2022, Biomolecules.

Lobeline Analogs with Enhanced Affinity and Selectivity for Plasmalemma and Vesicular Monoamine Transporters

L. Dwoskin, P. Crooks, S. Norrholm, 2004, Journal of Pharmacology and Experimental Therapeutics.

Potential therapeutic uses of mecamylamine and its stereoisomers

L. Dwoskin, J. Nickell, K. Siripurapu, 2013, Pharmacology Biochemistry and Behavior.

Heterologous Expression of Human α6β4β3α5 Nicotinic Acetylcholine Receptors: Binding Properties Consistent with Their Natural Expression Require Quaternary Subunit Assembly Including the α5 Subunit

R. Lukas, M. Bencherif, L. Pradier, 2005, Journal of Pharmacology and Experimental Therapeutics.

Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine

D. Kombo, T. Hauser, D. Yohannes, 2012, Neuropharmacology.

Linking Ethanol-Addictive Behaviors With Brain Catecholamines: Release Pattern Matters

R. Gainetdinov, E. Budygin, E. Krupitsky, 2021, Frontiers in Behavioral Neuroscience.

Atypical antipsychotics as noncompetitive inhibitors of α4β2 and α7 neuronal nicotinic receptors

R. Papke, M. Bencherif, P. Lippiello, 2009, Neuropharmacology.

Atypical antipsychotics as noncompetitive inhibitors of a 4 b 2 and a 7 neuronal nicotinic receptors

R. Papke, M. Bencherif, P. Lippiello, 2022 .

Behavioral profile of adult zebrafish acutely exposed to a selective dopamine uptake inhibitor, GBR 12909

E. Budygin, A. Kalueff, K. Zabegalov, 2023, Journal of psychopharmacology.

[Interaction of simple tetrahydroisoquinolines with opiate and high-affinity dopamine (D3) receptors in the rat corpus striatum].

V. Grinevich, A. A. Patsenko, I. Ostrovskii, 1987, Farmakologiia i toksikologiia.

Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.

L. Dwoskin, P. Crooks, A. Deaciuc, 2004, Bioorganic & medicinal chemistry letters.

bis-azaaromatic quaternary ammonium analogues: Ligands for α4β2* and α7* subtypes of neuronal nicotinic receptors

L. Dwoskin, P. Crooks, A. Deaciuc, 2002 .

Synthesis and evaluation of conformationally restricted pyridino N‐alkylated nicotine analogs as nicotinic acetylcholine receptor antagonists

L. Dwoskin, P. Crooks, Sangeetha P. Sumithran, 2002 .

Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR).

D. Kombo, Kartik Tallapragada, J. Chewning, 2013, Bioorganic & medicinal chemistry letters.

N-n-Alkylpyridinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Selective Inhibition of Nicotine-Evoked [3H]Dopamine Overflow from Superfused Rat Striatal Slices

L. Dwoskin, P. Crooks, Aaron J Haubner, 2003, Journal of Pharmacology and Experimental Therapeutics.

N-n-Alkylpyridinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Selective Inhibition of Nicotine-Evoked [3H]Dopamine Overflow from Superfused Rat Striatal Slices

L. Dwoskin, P. Crooks, Aaron J Haubner, 2003, Journal of Pharmacology and Experimental Therapeutics.

N-n -Alkylnicotinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Interaction with (cid:1) 4 (cid:2) 2* and (cid:1) 7* Neuronal Nicotinic Receptors

L. Dwoskin, V. Grinevich, Peter A. Crooks, 2002 .